Be part of the knowledge - Prova Education

Medical News

news-medical.net
03/19/2023
Medical News
MS Relapse Risk Not Likely to Increase After Fertility Treatments, Study Finds
Read more
medicalxpress.com
03/19/2023
Medical News
Study Evaluates the Impact of Dental Office Closures During COVID-19 on Dental …
Read more
sciencedaily.com
03/19/2023
Medical News
New Test Quickly Identifies Patients Whose Postoperative Pain Can Be Effectivel…
Read more

Popular

- Tanios S. Bekaii-Saab, MD
  Peer
- Joleen M. Hubbard, MD
  Peer
2
CME/CE
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
0.25 credits
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
0.25 credits
- Sara W. Koblitz
  Peer
- Michael J. Thorpy, MD
  Peer
0
CME/CE
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue, but a “Patent” Issue on the Cusp
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue, but a “Patent” Issue on the Cusp
0.25 credits
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue,…
0.25 credits
- Jillian Ziemanski, OD, PhD, FAAO
  Peer
- Cynthia Matossian, MD, FACS
  Peer
2
CME/CE
Improving Meibomian Gland Dysfunction with Device Management
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
- Peter G. Pappas, MD, FACP
  Peer
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
2
CME/CE
Invasive Fungal Infections: More Common Than You Think
Invasive Fungal Infections: More Common Than You Think
0.25 credits
Invasive Fungal Infections: More Common Than You Think
0.25 credits
- Saad Z. Usmani, MD, MBA, FACP
  Peer
- Sikander Ailawadhi, MD
  Peer
- Amrita Krishnan, MD
  Peer
2
CME/CE Broadcast Replay
CME/CE Broadcast Replay
BCMA Who and When: Immunotherapies in Patients with RRMM
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
- Sara W. Koblitz
  Peer
- Michael J. Thorpy, MD
  Peer
9
CME/CE
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
0.25 credits
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxyba…
0.25 credits

CME/CE

- Ezra Cohen, MD, FRCPSC, FASCO
  Peer
- Petr Szturz, MD, PhD
  Peer
0
CME/CE
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
0.25 credits
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastati…
0.25 credits
- Sara W. Koblitz
  Peer
- Michael J. Thorpy, MD
  Peer
0
CME/CE
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue, but a “Patent” Issue on the Cusp
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue, but a “Patent” Issue on the Cusp
0.25 credits
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue,…
0.25 credits
- Danielle Becker, MD, MS, FAES
  Peer
- Ahmed Abdelmoity, MD
  Peer
- Deborah Holder, MD
  Peer
- John Stern, MD
  Peer
0
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
0.25 credits
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Pati…
0.25 credits
- Steven Flamm, MD
  Peer
- Tiffany E. Kaiser, PharmD
  Peer
- Mazen Noureddin, MD
  Peer
8
CME/CE Meeting
CME/CE Meeting
NASH: An Epidemic with Enormous Health …
March 21, 2023
06:00 PM - 08:00 PM CDT
1.50 credits Learn more
- Jillian Ziemanski, OD, PhD, FAAO
  Peer
- Cynthia Matossian, MD, FACS
  Peer
2
CME/CE
Improving Meibomian Gland Dysfunction with Device Management
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
- Sara W. Koblitz
  Peer
- Michael J. Thorpy, MD
  Peer
9
CME/CE
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
0.25 credits
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxyba…
0.25 credits

Clinical Practice

- Andrew H. Lipsky, MD
  Peer
- Jacob D. Soumerai, MD
  Peer
- Catherine C. Coombs, MD
  Peer
0
CME/CE Broadcast Replay
CME/CE Broadcast Replay
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now and Preparing for the Future
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now and Preparing for the Future
1.00 credit
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now an…
1.00 credit
- Saad Z. Usmani, MD, MBA, FACP
  Peer
- Sikander Ailawadhi, MD
  Peer
- Amrita Krishnan, MD
  Peer
2
CME/CE Broadcast Replay
CME/CE Broadcast Replay
BCMA Who and When: Immunotherapies in Patients with RRMM
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
5
Minute CME/CE™
Importance & Benefits of Early Diagnosis
Importance & Benefits of Early Diagnosis
1.00 program credit
Importance & Benefits of Early Diagnosis
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
The Role of Biomarkers in Alzheimer's Disease
The Role of Biomarkers in Alzheimer's Disease
1.00 program credit
The Role of Biomarkers in Alzheimer's Disease
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
1
Minute CME/CE™
Additional Treatments for Alzheimer's Disease
Additional Treatments for Alzheimer's Disease
1.00 program credit
Additional Treatments for Alzheimer's Disease
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
Standard of Care
Standard of Care
1.00 program credit
Standard of Care
1.00 program credit

Programs

- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
- George Thompson III, MD, FIDSA
  Peer
0
CME/CE
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
0.25 credits
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
0.25 credits
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
Prevention of Alzheimer's Disease
Prevention of Alzheimer's Disease
1.00 program credit
Prevention of Alzheimer's Disease
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
Differences Among Agents
Differences Among Agents
1.00 program credit
Differences Among Agents
1.00 program credit
- Marc E. Agronin, MD
  Peer
2
Minute CME/CE™
Pathology: Amyloid vs Tau
Pathology: Amyloid vs Tau
1.00 program credit
Pathology: Amyloid vs Tau
1.00 program credit
- Marc E. Agronin, MD
  Peer
2
Minute CME/CE™
Clinical Trials in Alzheimer's Disease
Clinical Trials in Alzheimer's Disease
1.00 program credit
Clinical Trials in Alzheimer's Disease
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
4
Minute CME/CE™
What Is Immunotherapy?
What Is Immunotherapy?
1.00 program credit
What Is Immunotherapy?
1.00 program credit